Abstract Details

Title Retinal Structure and Function During Adjunctive Vigabatrin Treatment: Case Reports of Potentially Significant Changes During a Phase IV Study

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P6 - (-)

Poster/Presentation
Number 248

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Kenneth D. Laxer, MD, FAAN (Sutter Pacific Medical Foundation) PRESENTER	Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
	No disclosure on file
Jeremy D. Slater, MD, FAAN (Stratus)	Dr. Slater has received personal compensation for serving as an employee of Stratus. Dr. Slater has stock in Zeto LLC.
Ekrem Kutluay, MD (Medical College of Wisconsin)	No disclosure on file
	No disclosure on file
Robert C. Sergott, MD (Wills Eye Hospital)	Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.

��ɫ��